Article
Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African children.
The Journal of antimicrobial chemotherapy - 1 Jan 2017
Bienczak Andrzej, Cook Adrian, Wiesner Lubbe, Mulenga Veronica, Kityo Cissy, Kekitiinwa Addy, Walker A Sarah, Owen Andrew, Gibb Diana M, Burger David, McIlleron Helen, Denti Paolo
Abstract excerpt
OBJECTIVES: To characterize the effects of CYP2B6 polymorphisms, diurnal variation and demographic factors on nevirapine pharmacokinetics in African children. METHODS: Non-linear mixed-effects modelling conducted in NONMEM 7.3 described nevirapine plasma concentration-time data from 414 children aged 0.3-15 years. RESULTS: Nevirapine pharmacokinetics was best described using a one-compartment disposition model...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
